Stanley Lau - Jun 30, 2023 Form 4 Insider Report for Cardio Diagnostics Holdings, Inc. (CDIO)

Role: Director
Signature: /s/ Elisa Luqman as attorney-in-fact for Stanley Lau
Stock symbol: CDIO
Transactions as of: Jun 30, 2023
Transactions value $: $73,999
Form type: 4
Date filed: 7/5/2023, 01:55 PM
Previous filing: Jun 21, 2023
Next filing: Oct 4, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDIO	Common Stock	Options Exercise	$25K	+21K		$1.19	21K	Jun 30, 2023	Direct	F1
transaction	CDIO	Common Stock	Options Exercise	$10K	+8.4K	+40%	$1.19	29.4K	Jul 1, 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDIO	Restricted Stock Units	Options Exercise	$25K				$25K	Jun 30, 2023	Common Stock	$25K	$0.00	Direct	F3, F4, F5
transaction	CDIO	Restricted Stock Units	Options Exercise	$14K				$39K	Jul 1, 2023	Common Stock	$14K	$0.00	Direct	F5, F6, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the settlement of restricted stock units (RSUs) that vested on June 30, 2023 through the issuance of shares of Common Stock.
F2	Represents the settlement of restricted stock units (RSUs) that vested on July 1, 2023 through the issuance of shares of Common Stock.
F3	Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On June 30, 2023, $25,000 in value of RSUs vested and were settled at the price of $1.19, which was the closing price of the Companys Common Stock on the vesting date. The settlement shares are reflected in Table I.
F4	On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, $25,000 in value of which vested on June 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $12,500 in value on September 30, 2023; and (ii) $12,500 in value on December 31, 2023.
F5	The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.
F6	Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On July 1, 2023, $10,000 in value of RSUs vested and were settled at the price of $1.19, which was the closing price of the Companys Common Stock on the vesting date. The settlement shares are reflected in Table I.
F7	On July 1, 2023, the reporting person was awarded $24,000 in value of RSUs, $10,000 in value of which vested on July 1, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $2,000 in value on July 31, 2023, (ii) $2,000 in value on August 31, 2023, (iii) $2,000 in value on September 30, 2023; (iv) $2,000 in value on October 31, 2023; (v) $2,000 in value on November 30, 2023; (vi) $2,000 in value on December 31, 2023 and (vii) $2,000 in value on January 31, 2024.